At the 2005 American Society of Human Genetics meeting, Francis Collins gave a presentation about a treatment he devised for children affected by Progeria. He discussed how farnesyltransferase inhibitors (FTIs) affects H-Ras. After his presentation, members of the<unk>  Family Network discussed the possibility of FTIs helping children with<unk> . Mark Kieran, who presented at the 1st International<unk>  Research Symposium in 2007, agreed that FTIs might help children with<unk> . He discussed with<unk>  advocates what he had learned in establishing and running the Progeria clinical trial with an FTI, to help them consider next steps. Another medication that affects H-Ras is Lovastatin, which is planned as a treatment for neurofibromatosis type I. When this was reported in mainstream news, the<unk>  Professional Advisory Board was asked about its use in<unk> . Research into the effects of Lovastatin was linked with Alcino Silva, who presented his findings at the 2007 symposium. Silva also believed that the medication he was studying could help children with<unk>  with cognition. A third medication that might help children with<unk>  is a MEK inhibitor that helps inhibit the pathway closer to the cell nucleus.
Costello syndrome
Perlman syndrome
Angelman syndrome
Ortner's syndrome
Young's syndrome
Irvine–Gass syndrome
Mondor's disease
Asherman's syndrome